10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001104659-17-050250`
Period End Date	20170630
Filing Date	20170808
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	cldx-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 62 Cash Flow Statement 57

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$42.46M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.48M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$66.16M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$87.82M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$147.31M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.36M	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.78M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.71M	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.01M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	120.52M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$160.05M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$195.57M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	127.41M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	120.52M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$13.19M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$12.07M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	127.41M	shares	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$81.49M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$81.04M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$2.13M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.94M	USD	Point-in-time
Goodwill	`Goodwill`	$90.98M	USD	Point-in-time
Goodwill	`Goodwill`	$90.98M	USD	Point-in-time
Total Assets	`Assets`	$383.36M	USD	Point-in-time
Total Assets	`Assets`	$346.07M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.74M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.98M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$28.66M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$21.27M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$5.54M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$4.83M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$28.79M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$35.22M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$82.70M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$85.83M	USD	Point-in-time
Total Liabilities	`Liabilities`	$114.61M	USD	Point-in-time
Total Liabilities	`Liabilities`	$117.93M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 127,411,975 and 120,516,654 Shares Issued and Outstanding at June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$127.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 127,411,975 and 120,516,654 Shares Issued and Outstanding at June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$121.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$1.01B	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$982.25M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.58M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.54M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-782.31M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-719.49M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$265.43M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$231.46M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$346.07M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$383.36M	USD	Point-in-time

Income Statement 62 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$1.25M	USD	2 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$1.06M	USD	2 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$604.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$694.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$4.11M	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$1.64M	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$785.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$3.13M	USD	1 Quarter
Total Revenue	`Revenues`	$3.83M	USD	1 Quarter
Total Revenue	`Revenues`	$2.69M	USD	2 Qtrs
Total Revenue	`Revenues`	$1.39M	USD	1 Quarter
Total Revenue	`Revenues`	$5.36M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$25.00M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$53.16M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$25.71M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$50.79M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$17.10M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$6.53M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$13.76M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$7.79M	USD	1 Quarter
Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$4.40M	USD	2 Qtrs
Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.00M	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$224.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$448.00K	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$70.76M	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$33.76M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$32.76M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$69.40M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-32.37M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-28.93M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-64.04M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-68.07M	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$414.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.45M	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$362.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.21M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.83M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.95M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-66.62M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.57M	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.67	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.32	USD	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	98.82M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	123.93M	shares	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	125.20M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	98.75M	shares	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.83M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.95M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-66.62M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.57M	USD	1 Quarter
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$416.00K	USD	2 Qtrs
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$36.00K	USD	1 Quarter
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$15.00K	USD	1 Quarter
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$36.00K	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-28.55M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-62.79M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-66.21M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-31.92M	USD	1 Quarter

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.83M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.95M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-66.62M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.57M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.43M	USD	2 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$2.37M	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$224.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$448.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$161.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-612.00K	USD	2 Qtrs
Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-74.00K	USD	2 Qtrs
Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$4.40M	USD	2 Qtrs
Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.00M	USD	1 Quarter
Stock-Based Compensation Expense	`ShareBasedCompensation`	$6.99M	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$7.91M	USD	2 Qtrs
Non-Cash Expense	`AmortizationOfDebtDiscountPremium`	$1.64M	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-425.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$146.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.12M	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$511.00K	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-199.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-6.81M	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-10.21M	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-566.00K	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-803.00K	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-56.05M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-68.73M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$149.37M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$151.47M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$120.05M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$91.97M	USD	2 Qtrs
Investment in Other	`PaymentsToAcquireOtherInvestments`	$1.80M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.32M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.31M	USD	2 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$58.19M	USD	2 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$26.21M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$21.49M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$2.55M	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$349.00K	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$76.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$2.90M	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$21.57M	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$23.70M	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-39.63M	USD	2 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$42.46M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$32.48M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$66.16M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$42.46M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$32.48M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$66.16M	USD	Point-in-time
Acquisition of Property and Equipment included in Accounts Payable and Accrued Expenses	`CapitalExpendituresIncurredButNotYetPaid`	$87.00K	USD	2 Qtrs
Acquisition of Property and Equipment included in Accounts Payable and Accrued Expenses	`CapitalExpendituresIncurredButNotYetPaid`	$108.00K	USD	2 Qtrs
Shares issued to former Kolltan executive for settlement of severance	`SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance`	$263.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.